BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22020421)

  • 1. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
    Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
    Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
    Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
    Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
    J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
    Srivastava P; Lone TA; Kapoor R; Mittal RD
    Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Duarte G; Tanus-Santos JE
    Exp Mol Pathol; 2012 Apr; 92(2):217-21. PubMed ID: 22327101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.
    Sabbatini AR; Barbaro NR; de Faria AP; Ritter AMV; Modolo R; Correa NB; Brunelli V; Pinho C; Fontana V; Moreno H
    Gene; 2017 Jul; 620():23-29. PubMed ID: 28390988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
    Srivastava P; Kapoor R; Mittal RD
    Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis.
    Kang S; Zhao X; Xing H; Wang N; Zhou R; Chen S; Li W; Zhao J; Duan Y; Sun D; Li Y
    Environ Mol Mutagen; 2008 Apr; 49(3):226-31. PubMed ID: 18288718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.
    Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M
    Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective role of the -735C/T and the -1306C/T polymorphisms of the MMP-2 gene in the development of primary open-angle glaucoma.
    Kaminska A; Banas-Lezanska P; Przybylowska K; Gacek M; Majsterek I; Szaflik J; Szaflik JP
    Ophthalmic Genet; 2014 Mar; 35(1):41-6. PubMed ID: 23725205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
    Sharma KL; Misra S; Kumar A; Mittal B
    Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
    Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
    Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
    Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
    Park YS; Jeon YJ; Kim HS; Han IB; Oh SH; Kim DS; Kim NK
    BMC Neurol; 2014 Oct; 14():180. PubMed ID: 25280484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
    Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
    Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.